{
    "_comment": "FY2024 Survey Answer Schema - stores only answers, questions are in template",
    "municipality": "Agawam",
    "response_id": "4",
    "contact": {
        "primary_name": "Cheryl St John",
        "primary_email": "auditor @agawam.ma.us",
        "primary_phone": "4137269707",
        "secondary_name": "Christopher Cappucci",
        "secondary_email": "ccappucci @agawam.ma.us",
        "secondary_phone": "4137269728"
    },
    "funding": {
        "municipality_name": "Agawam",
        "total_received_all_years": 414108.49,
        "carryover_from_previous": 0,
        "fy2024_disbursement": 222120.35,
        "total_available_fy24": 222120.35,
        "pooled": false,
        "pooling_details": {
            "ima_ssa_name": null,
            "interested_in_pooling": false,
            "interested_in_state_fund": false,
            "is_fiscal_agent": null,
            "fiscal_agent_name": null,
            "pooled_all_funding": null
        },
        "total_expended_fy24": 0,
        "total_unexpended": 222120.75
    },
    "commitments": {
        "engagement_grid": {
            "_comment": "G1: Who was engaged and how",
            "people_who_use_drugs": [],
            "people_in_recovery": [],
            "families_impacted": [],
            "subject_matter_experts": []
        },
        "engagement_descriptions": {
            "people_who_use_drugs_other": "",
            "barriers_people_who_use_drugs": "n/a",
            "barriers_people_in_recovery": "n/a",
            "barriers_families": "n/a",
            "barriers_experts": "n/a"
        },
        "disparities_assessment": {
            "_comment": "G2: How disparities were identified",
            "access_to_services": [],
            "health_outcomes_race": [],
            "health_outcomes_wealth": [],
            "stigma_impact": [],
            "provider_diversity": [],
            "admin_data_sources": "",
            "other_methods": ""
        },
        "behavioral_health_assessment": {
            "_comment": "G3: How behavioral health needs were assessed",
            "opioid_overdose": [],
            "fatal_overdoses": [],
            "emt_response": [],
            "admin_data_sources": "n/a",
            "other_methods": "n/a",
            "barriers": "n/a"
        },
        "existing_programs": {
            "_comment": "G4: Programs/services to leverage",
            "programs": []
        },
        "innovation_practices": {
            "_comment": "G5: Evidence-based practices",
            "practices": []
        }
    },
    "planning": {
        "process": "Our municipality conducted its own planning process.",
        "consultant_activities": null,
        "care_mass_activities": null,
        "documents_uploaded": null
    },
    "populations_served": {
        "specific_populations": false,
        "populations_list": [],
        "other_populations": "",
        "barriers": ""
    },
    "strategies": {
        "treatment": {
            "progress": "Planning",
            "expended": 0,
            "how_spent": [],
            "barriers": ""
        },
        "recovery_support": {
            "progress": "Planning",
            "expended": 0,
            "how_spent": [],
            "barriers": ""
        },
        "connections_to_care": {
            "progress": "Planning",
            "expended": 0,
            "how_spent": [],
            "barriers": ""
        },
        "harm_reduction": {
            "progress": "Early implementation",
            "expended": 0,
            "how_spent": [
                "Increase availability of naloxone and other drugs that treat overdoses for first responders, overdose patients, individuals with OUD and their friends and family, schools, community-based organizations, community navigators and outreach workers, persons being released from jail or prison, or the public",
                "Provide training and education regarding naloxone and other drugs that treat overdoses",
                "\"Naloxone Plus\" strategies to ensure that individuals who receive naloxone to reverse an overdose are linked to treatment programs or other appropriate services",
                "Approve and fund syringe service programs and other programs to reduce harms associated with drug use, including supplies, staffing, space, peer support services, referrals to treatment, fentanyl checking, syringe collection and disposal, connection to care, and the full range of harm reduction and treatment services provided by these programs",
                "Promote efforts to train health care providers, students, peer recovery coaches, recovery outreach specialists, or other professionals that provide care to persons who use opioids or persons with OUD in crisis training and harm reduction strategies"
            ],
            "barriers": ""
        },
        "criminal_justice": {
            "progress": "Planning",
            "expended": 0,
            "how_spent": [],
            "barriers": ""
        },
        "pregnant_parenting": {
            "progress": "No work in this area",
            "expended": 0,
            "how_spent": [],
            "barriers": "n/a"
        },
        "prevention": {
            "progress": "Planning",
            "expended": 0,
            "how_spent": [],
            "barriers": ""
        },
        "administrative": {
            "progress": "Planning",
            "expended": 0,
            "how_spent": [],
            "job_title": "",
            "fte": ""
        },
        "other": {
            "progress": "Early implementation",
            "expended": 0,
            "how_spent": [
                "Costs associated with planning and implementing opioid abatement activities to ensure the expenditure of allocated Opioid Abatement Funds is effective and meets the terms of the State Subdivision Agreement."
            ]
        }
    },
    "additional_comments": {
        "general": "",
        "unmet_needs": "",
        "orrf_recommendations": ""
    },
    "submission_url": "https://mosaic.rizema.org/wp-content/uploads/datadashboard/Agawam.pdf"
}